Radiation-free FEVAR with LumiGuide image guidance
Official title: Radiation Free Study
Run by Philips Clinical & Medical Affairs Global · NCT06549348 · Data updated 2026-11-12
This study will test whether using LumiGuide instead of standard fluoroscopy cuts X‑ray time during fenestrated endovascular aortic repair for adults who need visceral artery incorporation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 182 (estimated) |
| Sponsor | Philips Clinical & Medical Affairs Global Industry-sponsored |
| Locations | 11 sites (Birmingham, Alabama and 10 other locations) |
| Status | Recruiting |
| Started | July 3, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT06549348 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) undergoing a primary FEVAR that includes incorporation of visceral arteries (celiac, SMA, renal), able to give informed consent, with life expectancy ≥2 years, and meeting the trial's vessel-count and timing criteria are ideal candidates.
✕Probably not a fit
Patients undergoing branched or iliac branched device procedures, staged or re-intervention FEVAR, emergent (<24 hr) repairs, treatment of more than four target vessels, or those with connective tissue disorders are excluded and unlikely to benefit from this trial's approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, unblinded, multicenter comparison of LumiGuide image guidance versus conventional fluoroscopy during fenestrated endovascular aortic repair (FEVAR). Sites were chosen across the US and Europe to improve generalizability. The primary endpoint is average procedure fluoroscopy time measured for procedures that incorporate the celiac trunk, superior mesenteric artery, and renal arteries. Participants are adult patients undergoing primary FEVAR who meet vessel and timing eligibility and are randomized to LumiGuide or standard fluoroscopy guidance.
Why it matters
Potential benefit: If successful, the approach could substantially reduce patients' and staff's radiation exposure during complex aortic repair and may shorten imaging time.
How similar studies have gone: Prior studies of fusion imaging and navigation systems have shown reductions in fluoroscopy time for endovascular procedures, but randomized data specifically on LumiGuide are limited, making this a relatively novel randomized comparison.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject will be undergoing a primary Fenestrated Endovascular Aortic Repair (FEVAR) procedure (including subjects with prior infrarenal EVAR or open repair) that includes the incorporation of visceral arteries into the repair. * Subject is able to give informed consent and is 18 years of age or older, or of legal age to give informed consent per state or national law. * Subject has a life expectancy of at least 2 years * Target vessels to be included are the Celiac Trunk, Superior Mesenteric Artery and Renal Arteries Exclusion Criteria: * Subjects undergoing an endovascular procedure that include branches or iliac branched devices (IBD) in the repair * Subject treated for re-intervention / staged procedure post-primary FEVAR procedure * Subjects intended to be treated for more than 4 target vessels (not counting the contralateral gate) * Subject treated for an emergent (\<24hrs after emergence) procedure * Subject with connective tissue disorder eg, Marfan's or Ehlers Danlos Syndrome * Subject with contrast allergies * Subject participates in a potentially confounding drug or device trial during the course of the study. Co-enrollment in concurrent trials may be allowed provided that pre-approval is obtained from Philips. * All vulnerable subjects such as immuno-compromised subjects, subjects lacking the capacity to provide consent, patients in emergency situations, pregnant or breast-feeding women, or any other subject who meets an exclusion criteria, according to applicable national laws, if any. * Subject unwilling or unable to comply with the protocol unable to understand verbal and/or written informed consent
Where it's running
-
University of Alabama
Birmingham, Alabama, United States Recruiting -
University of Massachusetts
Worcester, Massachusetts, United States Recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
University of Texas Southwestern Medical Center
Dallas, Texas, United States Recruiting -
UZ Gent
Ghent, Belgium Recruiting -
Hôpital Universitaire Pitié-Salpêtrière
Paris, France Recruiting
Show 5 more locations
-
UMC Maastricht
Maastricht, Netherlands Recruiting -
Guys & St Thomas
London, United Kingdom Recruiting -
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States Not yet recruiting -
Rigshospitalet University Hospital
Copenhagen, Denmark Not yet recruiting -
University Medical Center Utrecht
Utrecht, Netherlands Not yet recruiting
Study contacts
- Study coordinator: Bart Wessels
- Email: bart.wessels@philips.com
- Phone: bart.wessels@philips.com
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Physician-modified endografts for aortic disease in high-risk patients
This study tests a physician-modified Terumo Treo abdominal stent-graft to see if it can safely treat large aortic aneurysms in patients who are high-risk for open surgery.
-
Using AI to measure aortic size from CT scans
This project will test whether an AI tool called Aorta AIM can automatically measure the aorta on CT scans for adults who have or are being checked for aortic aneurysms.
-
Measuring the shape and strength of the ascending aorta in patients having heart surgery
We will test whether direct measurements of the aortic wall's mechanical properties taken during heart surgery can better characterize rupture or dissection risk in people with ascending aortic aneurysm by comparing them to patients undergoing heart transplantation without known aortic disease.
-
Rapidlink device for repairing aortic arch branch vessels during open thoracic aorta surgery
This study will test whether the Rapidlink device can help surgeons repair or replace the arteries branching from the aortic arch during open surgery for thoracic aortic disease.
-
Using modified endovascular grafts to treat complex aortic aneurysms
This study is testing if specially modified grafts can safely repair complex aortic aneurysms in high-risk patients who can’t have regular surgery.
-
Understanding exercise effects on aortic aneurysm patients
This study is testing how exercise affects people with aortic aneurysms to help find safe activity levels that could improve their health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.